Why the study?
Does incomplete revascularization increase the risk of adverse clinical outcomes compared to complete revascularization in patients with active CAD undergoing TAVR?
Cohort (n=323)
No
Does incomplete revascularization increase the risk of adverse clinical outcomes compared to complete revascularization in patients with active CAD undergoing TAVR?
Answers are grounded in this paper and cite their sources.
In patients with active CAD undergoing TAVR, incomplete revascularization of a major epicardial artery is associated with an increased risk of subsequent AMI or revascularization compared to complete revascularization, though mortality is unaffected.
OBJECTIVES: This study reports on the clinical effects of complete vs incompletely revascularized coronary artery disease on transcatheter aortic valve replacement (TAVR). BACKGROUND: There is a high prevalence of active coronary artery disease (CAD) in patients undergoing TAVR but preemptive revascularization remains controversial. METHODS: Patients were categorized into three cohorts: complete revascularization (CR), incomplete revascularization of a major epicardial artery (IR Major), and incomplete revascularization of a minor epicardial artery only (IR Minor). When feasible, SYNTAX scoring was performed for exploratory analysis. Analyses were performed using Cox proportional hazard models and Kaplan-Meier method. RESULTS: A total of 323 patients with active CAD were included. Adjusted outcomes showed that patients with IR Major had increased incidence of acute myocardial infarction (AMI) or revascularization compared with those in the CR cohort (HR 3.72, P = 0.048). No difference was noted in all-cause mortality or all-cause readmission rates. Exploratory secondary analysis with residual SYNTAX scores showed a significant interaction between disease burden and AMI/revascularization, as well as all-cause readmission. All-cause mortality remained unaffected based on residual SYNTAX scores. CONCLUSIONS: This is a retrospective single-center study reporting on pre-TAVR revascularization outcomes in patients with active CAD. In this analysis, we found that patients undergoing TAVR benefited from achieving complete revascularization to abate future incidence of AMI/revascularization. Despite this finding, all-cause mortality remained unaffected. Future efforts should focus on the role of functional assessment of the coronaries, as well as the long-term effects of complete revascularization in a larger patient cohort.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) conducted a cohort in Active coronary artery disease in patients undergoing TAVR (n=323). Incomplete revascularization of a major epicardial artery (IR Major) vs. Complete revascularization (CR) was evaluated on Acute myocardial infarction (AMI) or revascularization (HR 3.72, p=0.048).
Synapse has enriched 10 related papers. Consider them for comparative context: